Efficacy and safety of intraperitoneal bevacizumab combined with hyperthermic intraperitoneal chemotherapy in the treatment of patients with ovarian cancer and peritoneal effusion and the effect on serum lncRNA H19 and VEGF levels

Efficacy and safety of intraperitoneal bevacizumab combined with hyperthermic intraperitoneal chemotherapy in the treatment of patients with ovarian cancer and peritoneal effusion and the effect on serum lncRNA H19 and VEGF levels

Peritoneal effusion is a common event in ovarian cancer (OC) patients. LncRNA H19 and vascular endothelial growth factor (VEGF) are implicated in cancer progression. The study evaluated the curative effect and safety of bevacizumab combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in O...

Full description

Bibliographic Details
Main Authors: Meiling Zhang, Yu Bao, Hong Zhang, Dongmei Li, Xinkuan Mei, Xianping Cheng
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Journal of Obstetrics and Gynaecology
Subjects:
ovarian cancer
peritoneal effusion
hyperthermic intraperitoneal chemotherapy
bevacizumab
curative effect
safety
lncrna h19
vascular endothelial growth factor
Online Access:http://dx.doi.org/10.1080/01443615.2023.2204940

Internet

http://dx.doi.org/10.1080/01443615.2023.2204940

Similar Items